In conclusion, our study demonstrates that the PD-L1 × CD47 aptamer-siRNA chimera represents a novel and effective strategy for selectively depleting tumor-infiltrating Treg cells and enhancing antitumor immunity (Fig. 7). The gene discussed is CD47; the disease is neoplasm.